Crossmark

Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s40780-019-0133-7

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wakai, Eri

Ikemura, Kenji

Sugimoto, Hiroko

Iwamoto, Takuya

Okuda, Masahiro http://orcid.org/0000-0002-5517-0918
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 2 November 2018

Accepted: 17 January 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Mie University Graduate School of Medicine and Faculty of Medicine (No. 3150). Informed consent was not obtained from participating patients, because the data were collected retrospectively from electronic medical records.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.